Business Context and Reporting Period
Marchex, Inc. filed a Form 8-K on November 20, 2018, reporting the completion of an acquisition. The company, based in Seattle, Washington, operates in the call monitoring and analytics sector.
Key Financial Metrics and Transaction Details
This filing details a specific acquisition transaction rather than periodic financial results. The key financial terms of the acquisition of SITA Laboratories, Inc. (d/b/a CallCap) are as follows:
- Total Consideration: $25 million in cash plus $10 million in Marchex Class B common stock.
- Stock Valuation: The $10 million stock value is calculated based on a 10-day trailing average of Marchex's closing price prior to closing.
- Payment Structure: 25% of the stock consideration will be issued on each of the first four annual anniversaries of the closing.
- Closing Date: November 20, 2018.
The filing does not provide Marchex's current revenue, profit, cash flow, margins, debt, or liquidity metrics. Pro forma financial information and financial statements of the acquired business are scheduled to be filed by amendment within 71 calendar days.
Material Changes
The primary material change is the expansion of Marchex's operations through the acquisition of CallCap, a Wichita, Kansas-based call monitoring and analytics company. This represents a strategic entry or expansion into the analytics space via a definitive asset purchase.
Guidance, Risks, and Contingencies
Management Commentary and Outlook: The filing includes a press release (Exhibit 99.1) announcing the closing but does not contain specific forward-looking financial guidance within the text of the 8-K itself.
Risks and Contingencies:
- Forward-Looking Statements: The report contains forward-looking statements regarding strategy and future operations, which are subject to substantial risks and uncertainties.
- Indemnification: The Share Purchase Agreement includes customary representations and warranties, with CallCap stockholders required to indemnify Marchex for certain liabilities, partially secured by an escrow.
- Registration Obligations: Marchex must use commercially reasonable efforts to file a registration statement for the resale of the issued common stock within five business days after each issuance.
Investor Verification Checklist
- Verify the final share count issued for the $10 million stock component based on the 10-day trailing average price.
- Review the upcoming amendment to this 8-K (due within 71 days) for CallCap's historical financial statements and pro forma combined financial information.
- Examine the full text of the Share Purchase Agreement (to be filed as an exhibit) for specific indemnification limitations and escrow terms.
- Monitor future filings for the issuance schedule of the deferred stock payments over the next four years.